Rat brain docosahexaenoic acid metabolism is not altered by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide

Neurochemistry International

Volumn 56, Issue 3, 2010, Pages 501-507

  Rosenberger, Thad A ^a   Villacreses, Nelly E ^c   Weis, Margaret T ^b   Rapoport, Stanley I ^c  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Brain; Docosahexaenoic acid; Lipopolysaccharide; Metabolism; Neuroinflammation

Indexed keywords

ARACHIDONIC ACID; CALCIUM ION; DOCOSAHEXAENOIC ACID; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; PHOSPHOLIPASE A2; PHOSPHOLIPID; PROSTAGLANDIN D2; PROSTAGLANDIN E2;

AMINO ACID BRAIN LEVEL; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN VENTRICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; LIPID BRAIN LEVEL; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARACHIDONIC ACID; BRAIN; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; ENCEPHALITIS; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENTRICULAR; LIPID METABOLISM; LIPOPOLYSACCHARIDES; MEMBRANE LIPIDS; MICROSOMES; PHOSPHOLIPIDS; RATS; UP-REGULATION;

BACTERIA (MICROORGANISMS); RATTUS;

EID: 77049083373     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.12.010     Document Type: Article

References (71)

1. 2 by bromoenol lactone and trifluoromethyl ketones. J. Biol. Chem. 1995, 270:445-450.
2. 3H)glycerol. Biochim. Biophys. Acta 1970, 210:15-27.
3. Ansell G.B. Phospholipids and the nervous system. Form and Function of Phospholipids 1973, vol. 3:377-422. Elsevier, New York.
4. Arvindakshan M., Sitasawad S., Debsikdar V., Ghate M., Evans D., Horrobin D.F., Bennett C., Ranjekar P.K., Mahadik S.P. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biol. Psychiatry 2003, 53:56-64.
5. Barcelo-Coblijn G., Kitajka K., Puskas L.G., Hogyes E., Zvara A., Hackler L., Farkas T. Gene expression and molecular composition of phospholipids in rat brain in relation to dietary n-6 to n-3 fatty acid ratio. Biochim. Biophys. Acta 2003, 1632:72-79.
6. Basselin M., Villacreses N.E., Lee H.J., Bell J.M., Rapoport S.I. Chronic lithium administration attenuates up-regulated brain arachidonic acid metabolism in a rat model of neuroinflammation. J. Neurochem. 2007, 102:761-772.
7. Bazan N.G., Colangelo V., Lukiw W.J. Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins Other Lipid Mediat. 2002, 68-69:197-210.
8. 2 in brain cell and tissue injury associated with ischemia and excitotoxicity. J. Lipid Mediat. Cell Signal. 1997, 17:71-79.
9. 2 concentration in rat brain. Mol. Psychiatry 2002, 7:845-850.
10. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
11. Breckenridge W.C., Kuksis A. Specific distribution of short-chain fatty acids in molecular distillates of bovine milk fat. J. Lipid Res. 1968, 9:388-393.
12. Calabrese J.R., Bowden C., Woyshville M.J. Lithium and the anticonvulsants in the treatment of bipolar disorder. Phychopharmacology: The Fourth Generation of Progress 1995, 1099-1111. Raven, New York. E. Bloom, D. Kupfer (Eds.).
13. Calabrese J.R., Woyshville M.J. Lithium therapy: limitations and alternatives in the treatment of bipolar disorders. Ann. Clin. Psychiatry 1995, 7:103-112.
14. Chang M.C., Bell J.M., Purdon A.D., Chikhale E.G., Grange E. Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment. Neurochem. Res. 1999, 24:399-406.
15. Chang M.C., Grange E., Rabin O., Bell J.M., Allen D.D., Rapoport S.I. Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci. Lett. 1996, 220:171-174.
16. 2. J. Lipid Mediat. Cell Signal. 1995, 12:83-117.
17. Coleman R.A., Lewin T.M., Van Horn C.G., Gonzalez-Baro M.R. Do long-chain acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative pathways?. J. Nutr. 2002, 132:2123-2126.
18. Contreras M.A., Chang M.C., Rosenberger T.A., Greiner R.S., Myers C.S., Salem N., Rapoport S.I. Chronic nutritional deprivation of n-3 alpha-linolenic acid does not affect n-6 arachidonic acid recycling within brain phospholipids of awake rats. J. Neurochem. 2001, 79:1090-1099.
19. Contreras M.A., Greiner R.S., Chang M.C., Myers C.S., Salem N., Rapoport S.I. Nutritional deprivation of alpha-linolenic acid decreases but does not abolish turnover and availability of unacylated docosahexaenoic acid and docosahexaenoyl-CoA in rat brain. J. Neurochem. 2000, 75:2392-2400.
20. Crawford M.A., Golfetto I., Ghebremeskel K., Min Y., Moodley T., Poston L., Phylactos A., Cunnane S., Schmidt W. The potential role for arachidonic and docosahexaenoic acids in protection against some central nervous system injuries in preterm infants. Lipids 2003, 38:303-315.
21. 2. J. Biol. Chem. 1994, 269:13057-13060.
22. Deutsch J., Grange E., Rapoport S.I., Purdon A.D. Isolation and quantitation of long-chain acyl-coenzyme A esters in brain tissue by solid-phase extraction. Anal. Biochem. 1994, 220:321-323.
23. Dinarello C.A. The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 2002, 20:S1-13.
24. 2 translocation to internal membranes. J. Biol. Chem. 2001, 276:30150-30160.
25. 2 and its role in brain tissue. J. Neurochem. 1997, 69:889-901.
26. Flower R., Gryglewski R., Herbaczynska-Cedro K., Vane J.R. Effects of anti-inflammatory drugs on prostaglandin biosynthesis. Nat. New Biol. 1972, 238:104-106.
27. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissue. J. Biol. Chem. 1957, 226:497-509.
28. Fujino T., Kang M.J., Suzuki H., Iijima H., Yamamoto T. Molecular characterization and expression of rat acyl-CoA synthetase 3. J. Biol. Chem. 1996, 271:16748-16752.
29. Ghirnikar R.S., Lee Y.L., He T.R., Eng L.F. Chemokine expression in rat stab wound brain injury. J. Neurosci. Res. 1996, 46:727-733.
30. Golovko M.Y., Rosenberger T.A., Faergeman N.J., Feddersen S., Cole N.B., Pribill I., Berger J., Nussbaum R.L., Murphy E.J. Acyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism. Biochemistry 2006, 45:6956-6966.
31. Grange E., Deutsch J., Smith Q.R., Chang M., Rapoport S.I., Purdon A.D. Specific activity of brain palmitoyl-CoA pool provides rates of incorporation of palmitate in brain phospholipids in awake rats. J. Neurochem. 1995, 65:2290-2298.
32. Greiner R.S., Moriguchi T., Slotnick B.M., Hutton A., Salem N. Olfactory discrimination deficits in n-3 fatty acid-deficient rats. Physiol. Behav. 2001, 72:379-385.
33. Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J.D., Wenk G.L. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res. 1998, 780:294-303.
34. Hauss-Wegrzyniak B., Lukovic L., Bigaud M., Stoeckel M.E. Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study. Brain Res. 1998, 794:211-224.
35. 2 and transactivation of cyclooxygenase-2. J. Neurochem. 1999, 73:1641-1649.
36. Hong S., Gronert K., Devchand P.R., Moussignac R.L., Serhan C.N. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol. Chem. 2003, 278:14677-14687.
37. Iijima H., Fujino T., Minekura H., Suzuki H., Kang M.J., Yamamoto T. Biochemical studies of two rat acyl-CoA synthetases, ACS1 and ACS2. Eur. J. Biochem. 1996, 242:186-190.
38. Jolly C.A., Hubbell T., Behnke W.D., Schroeder F. Fatty acid binding protein: stimulation of microsomal phosphatidic acid formation. Arch. Biochem. Biophys. 1997, 341:112-121.
39. 2). FEBS Lett. 1997, 410:49-53.
40. Laposata M., Reich E.L., Majerus P.W. Arachidonoyl-CoA synthetase. Separation from nonspecific acyl-CoA synthetase and distribution in various cells and tissues. J. Biol. Chem. 1985, 260:11016-11020.
41. Lee H., Villacreses N.E., Rapoport S.I., Rosenberger T.A. In vivo imaging detects a transient increase in brain arachidonic acid metabolism: a potential marker of neuroinflammation. J. Neurochem. 2004, 91:936-945.
42. Lewin T.M., Kim J.H., Granger D.A., Vance J.E., Coleman R.A. Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. J. Biol. Chem. 2001, 276:24674-24679.
43. 2 by the p55 TNF receptor occurs independently of FAN. Biochem. Biophys. Res. Commun. 2000, 274:506-512.
44. Marcheselli V.L., Hong S., Lukiw W.J., et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 2003, 278:43807-43817.
45. Marszalek J.R., Kitidis C., Dirusso C.C., Lodish H.F. Long-chain acyl CoA synthetase 6 preferentially promotes DHA metabolism. J. Biol. Chem. 2005, 280:10817-10826.
46. Murphy E.J., Stephens R., Jurkowitz-Alexander M., Horrocks L.A. Acidic hydrolysis of plasmalogens followed by high-performance liquid chromatography. Lipids 1993, 28:565-568.
47. Radin N.S. Extraction of tissue lipids with a solvent of low toxicity. Methods Enzymol. 1981, 72:5-7.
48. Rapoport S.I. In vivo fatty acid incorporation into brain phospholipids in relation to plasma availability, signal transduction and membrane remodeling. J. Mol. Neurosci. 2001, 16:243-261.
49. Rapoport S.I. Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease. Prostaglandins Leukot. Essent. Fatty Acids 2008, 79:153-156.
50. 2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J. Biol. Chem. 1994, 269:15619-15624.
51. 2 is a target for chronic lithium in rat brain. Neuroreport 1999, 10:3887-3890.
52. Robinson P.J., Noronha J., DeGeorge J.J., Freed L.M., Nariai T., Rapoport S.I. A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res. Brain Res. Rev. 1992, 17:187-214.
53. Rosenberger T.A., Villacreses N.E., Hovda J.T., Bosetti F., Weerasinghe G., Wine R.N., Harry G.J., Rapoport S.I. Rat brain arachidonic acid metabolism is increased by a six-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J. Neurochem. 2004, 88:1168-1178.
54. Rosi S., Ramirez-Amaya V., Hauss-Wegrzyniak B., Wenk G.L. Chronic brain inflammation leads to a decline in hippocampal NMDA-R1 receptors. J. Neuroinflamm. 2004, 1:12.
55. 2 and cyclooxygenase-2 in the hippocampus after kainate lesions. Brain Res. 1998, 788:223-231.
56. 2+. Biochem. J. 1996, 313(Pt 3):849-853.
57. 2-cyclooxygenase pathways in inflammation. J. Leukoc. Biol. 1999, 66:535-541.
58. 2+ response in rat astrocytes by endogenous arachidonic acid liberation. J. Neurochem. 2002, 82:1252-1261.
59. Serhan C.N., Hong S., Gronert K., Colgan S.P., Devchand P.R., Mirick G., Moussignac R.L. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 2002, 196:1025-1037.
60. Shimizu T., Wolfe L.S. Arachidonic acid cascade and signal transduction. J. Neurochem. 1990, 55:1-15.
61. 2+. Br. J. Pharmacol. 2003, 139:1014-1022.
62. 2 and n-3 polyunsaturated fatty acid docosahexaenoic acid in prostanoid production in brain: perspectives for protection in neuroinflammation. Int. J. Dev. Neurosci. 2004, 22:551-557.
63. Tang P.Z., Tsai-Morris C.H., Dufau M.L. Cloning and characterization of a hormonally regulated rat long chain acyl-CoA synthetase. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:6581-6586.
64. Uberti M.A., Pierce J., Weis M.T. Molecular characterization of a rabbit long-chain fatty acyl CoA synthetase that is highly expressed in the vascular endothelium. Biochim. Biophys. Acta 2003, 1645:193-204.
65. Waku K. Origins and fates of fatty acyl-CoA esters. Biochim. Biophys. Acta 1992, 1124:101-111.
66. 3H]arachidonate in the anesthetized rat. J. Neurochem. 1994, 63:727-736.
67. Watkins P.A. Fatty acid activation. Prog. Lipid Res. 1997, 36:55-83.
68. 2 or lipoxygenase/cytochrome P450 pathways. Brain Res. Bull. 2004, 63:485-489.
69. Wenk G., Hauss-Wegrzyniak B., Willard L.B. Pathological and biochemical studies of chronic neuroinflammation may lead to therapies for Alzheimers's disease. Research and Perspectives in Neurosciences 2000, 73-77. Springer-Verlag, Berlin. P.H. Patterson, C. Kordon, Y. Christein (Eds.).
70. Willard L.B., Hauss-Wegrzyniak B., Wenk G.L. Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience 1999, 88:193-200.
71. Wilson D.B., Prescott S.M., Majerus P.W. Discovery of an arachidonoyl coenzyme A synthetase in human platelets. J. Biol. Chem. 1982, 257:3510-3515.